Format

Send to

Choose Destination
Future Oncol. 2014;10(9):1709-17. doi: 10.2217/fon.14.39.

Lysyl oxidase in cancer research.

Author information

1
Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Ole Maal√łes Vej 5, Copenhagen 2200, Denmark.

Abstract

Metastasis is the main reason for cancer-associated deaths and therapies are desperately needed to target the progression of cancer. Lysyl oxidase (LOX) plays a pivotal role in cancer progression, including metastasis, and is therefore is an attractive therapeutic target. In this review we will breakdown the process of cancer progression and the various roles that LOX plays has in the advancement of cancer. We will highlight why LOX is an exciting therapeutic target for the future.

KEYWORDS:

angiogenesis; cancer; extracellular matrix; lysyl oxidase; metastasis; premetastatic niche; prognostic markers; stroma; therapeutic targets

PMID:
25145437
DOI:
10.2217/fon.14.39
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center